bf/NASDAQ:NEO_icon.png

NASDAQ:NEO

NeoGenomics, Inc.

  • Stock

7.26

+13.53%

1.08

USD last updated 21/08 01:59:19

Last Close

6.18

21/08 20:01

Market Cap

1.73B

Beta: 1.12

Volume Today

7.04M

Avg: 1.25M

PE Ratio

−18.59

PFCF: −36.57

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.3-0.2-0.10.12018-10-302020-04-282021-12-312023-08-082024-11-04

    Revenue (Estimate*)

    50M100M150M200M2018-10-302020-04-282021-12-312023-08-082024-11-04

    *Estimate based on analyst consensus